M

Maccura Biotechnology Co Ltd
SZSE:300463

Watchlist Manager
Maccura Biotechnology Co Ltd
SZSE:300463
Watchlist
Price: 13.84 CNY -4.95% Market Closed
Market Cap: 8.5B CNY
Have any thoughts about
Maccura Biotechnology Co Ltd?
Write Note

Operating Margin
Maccura Biotechnology Co Ltd

13.6%
Current
21%
Average
2.4%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
13.6%
=
Operating Profit
370.3m
/
Revenue
2.7B

Operating Margin Across Competitors

Country CN
Market Cap 8.5B CNY
Operating Margin
14%
Country US
Market Cap 1.3T USD
Operating Margin
14%
Country US
Market Cap 196.3B USD
Operating Margin
17%
Country US
Market Cap 170.3B USD
Operating Margin
21%
Country KR
Market Cap 66.5T KRW
Operating Margin
31%
Country CH
Market Cap 37.6B CHF
Operating Margin
13%
Country US
Market Cap 38.5B USD
Operating Margin
25%
Country US
Market Cap 36.7B USD
Operating Margin
14%
Country US
Market Cap 26.4B USD
Operating Margin
28%
Country US
Market Cap 23B USD
Operating Margin
20%
Country US
Market Cap 22.3B USD
Operating Margin
8%
No Stocks Found

Maccura Biotechnology Co Ltd
Glance View

Market Cap
8.5B CNY
Industry
Life Sciences Tools & Services

Maccura Biotechnology Co., Ltd. engages in the research, development, production, sale, and service of in vitro diagnostic products. The company is headquartered in Chengdu, Sichuan and currently employs 2,901 full-time employees. The company went IPO on 2015-05-28. The firm provides hundreds of products which cover clinical biochemistry, chemiluminescent immunoassay, rapid diagnosis, thrombosis, hemostasis, and molecular diagnosis.

Intrinsic Value
13.67 CNY
Overvaluation 1%
Intrinsic Value
Price
M

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
13.6%
=
Operating Profit
370.3m
/
Revenue
2.7B
What is the Operating Margin of Maccura Biotechnology Co Ltd?

Based on Maccura Biotechnology Co Ltd's most recent financial statements, the company has Operating Margin of 13.6%.